Norharmane as a potential chemical entity for development of anticancer drugs

Eur J Med Chem. 2019 Jan 15:162:752-764. doi: 10.1016/j.ejmech.2018.11.024. Epub 2018 Nov 13.

Abstract

Cancer is a leading cause of death generally, and to overcome this problem the introduction of a new drug developing is a continuous endeavour. An alkaloid, norharmane and its derivatives, which have anticancer activities, widely distributed in several living and synthetic chemical sources. Herewith, the suggested mechanisms of organic reactions and synthetic approaches of norharmane available so far were considered. Active sites of norharmane nucleus positions, C-1, C-3, and N-9, were used for developing new molecules and based on structure activity relationship (SAR), those have been seen with anticancer activities. This review summarizes on chemistry of synthetic strategies of norharmane derivatives, which may provide a framework to design a novel anticancer drug, in future.

Keywords: 9H-pyrido[3,4-b]indole; Chemical synthesis; Cytotoxicity; SAR.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Carbolines / chemistry*
  • Catalytic Domain
  • Drug Design*
  • Humans
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Carbolines
  • norharman